Oene Mark Van's Insider Trades & SAST Disclosures
Oene Mark Van's most recent trade in Pacific Biosciences of California Inc was a trade of 898,352 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 19, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Oene Mark Van.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacific Biosciences of Cal... | Oene Mark Van | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2025 | 898,352 | 898,352 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Oene Mark Van | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2025 | 449,176 | 1,946,871 (1%) | 0% | 0 | Common Stock | |
| Pacific Biosciences of Cal... | Oene Mark Van | See Remarks | Sale of securities on an exchange or to another person at price $ 1.41 per share. | 03 Mar 2025 | 6,486 | 1,497,695 (0%) | 0% | 1.4 | 9,126 | Common Stock |
| Pacific Biosciences of Cal... | Oene Mark Van | See Remarks | Sale of securities on an exchange or to another person at price $ 1.88 per share. | 18 Feb 2025 | 100,773 | 1,496,681 (0%) | 0% | 1.9 | 189,252 | Common Stock |
| Pacific Biosciences of Cal... | Oene Mark Van | See Remarks | Sale of securities on an exchange or to another person at price $ 2.03 per share. | 10 Jan 2025 | 34,405 | 1,597,454 (1%) | 0% | 2.0 | 69,980 | Common Stock |
| Pacific Biosciences of Cal... | Oene Mark Van | See Remarks | Sale of securities on an exchange or to another person at price $ 1.66 per share. | 16 Aug 2024 | 38,011 | 1,630,815 (1%) | 0% | 1.7 | 63,174 | Common Stock |
| Pacific Biosciences of Cal... | Oene Mark Van | See Remarks | Sale of securities on an exchange or to another person at price $ 4.87 per share. | 04 Mar 2024 | 9,186 | 1,668,826 (1%) | 0% | 4.9 | 44,745 | Common Stock |
| Pacific Biosciences of Cal... | Van Mark Oene | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 798,076 | 1,674,687 (1%) | 0% | 0 | Common Stock | |
| Pacific Biosciences of Cal... | Oene Van Mark | See Remarks | Sale of securities on an exchange or to another person at price $ 5.96 per share. | 16 Feb 2024 | 33,560 | 876,611 (0%) | 0% | 6.0 | 199,950 | Common Stock |
| Pacific Biosciences of Cal... | Van Oene Mark | See Remarks | Sale of securities on an exchange or to another person at price $ 7.77 per share. | 09 Jan 2024 | 31,012 | 910,171 (0%) | 0% | 7.8 | 241,056 | Common Stock |
| Pacific Biosciences of Cal... | Mark Oene Van | See Remarks | Sale of securities on an exchange or to another person at price $ 11.00 per share. | 16 Aug 2023 | 26,102 | 939,769 (0%) | 0% | 11 | 287,122 | Common Stock |
| Pacific Biosciences of Cal... | Mark Oene Van | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 328,500 | 972,139 (0%) | 0% | 0 | Common Stock | |
| Pacific Biosciences of Cal... | Van Mark Oene | See Remarks | Sale of securities on an exchange or to another person at price $ 9.49 per share. | 02 Mar 2023 | 6,268 | 965,871 (0%) | 0% | 9.5 | 59,502 | Common Stock |
| Pacific Biosciences of Cal... | Mark Van Oene | See Remarks | Sale of securities on an exchange or to another person at price $ 9.53 per share. | 10 Jan 2023 | 26,722 | 640,808 (0%) | 0% | 9.5 | 254,768 | Common Stock |
| Illumina Inc | Oene Mark Van | SVP Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.72 per share. | 05 Nov 2020 | 1,073 | 16,575 (0%) | 0% | 311.7 | 334,476 | Common Stock |
| Illumina Inc | Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 355.04 per share. | 01 Sep 2020 | 585 | 17,688 (0%) | 0% | 355.0 | 207,698 | Common Stock |
| Illumina Inc | Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 356.38 per share. | 01 Sep 2020 | 40 | 17,648 (0%) | 0% | 356.4 | 14,255 | Common Stock |
| Illumina Inc | Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 385.43 per share. | 03 Aug 2020 | 625 | 18,255 (0%) | 0% | 385.4 | 240,894 | Common Stock |
| Illumina Inc | Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 370.10 per share. | 01 Jul 2020 | 400 | 18,880 (0%) | 0% | 370.1 | 148,040 | Common Stock |
| Illumina Inc | Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 367.68 per share. | 01 Jul 2020 | 125 | 19,380 (0%) | 0% | 367.7 | 45,960 | Common Stock |
| Illumina Inc | Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 368.74 per share. | 01 Jul 2020 | 100 | 19,280 (0%) | 0% | 368.7 | 36,874 | Common Stock |
| Illumina Inc | Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 361.44 per share. | 01 Jun 2020 | 525 | 19,605 (0%) | 0% | 361.4 | 189,756 | Common Stock |
| Illumina Inc | Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 362.07 per share. | 01 Jun 2020 | 100 | 19,505 (0%) | 0% | 362.1 | 36,207 | Common Stock |
| Illumina Inc | Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 316.82 per share. | 01 May 2020 | 525 | 20,230 (0%) | 0% | 316.8 | 166,331 | Common Stock |
| Illumina Inc | Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 316.86 per share. | 01 May 2020 | 100 | 20,130 (0%) | 0% | 316.9 | 31,686 | Common Stock |
| Illumina Inc | Oene Mark Van | SVP Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 300.22 per share. | 16 Apr 2020 | 1,250 | 20,755 (0%) | 0% | 300.2 | 375,275 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges